Impinj, Inc. — Form 10-Q Summary
Reporting period: Quarter ended September 30, 2020; filed October 28, 2020. Impinj develops and sells RAIN RFID products and services, including endpoint ICs and reader systems. It reports one operating segment.
Financial performance
| Metric | Q3 2020 | Q3 2019 | Nine months 2020 | Nine months 2019 |
|---|---|---|---|---|
| Revenue | $28.2 million | $40.8 million | $102.5 million | $112.0 million |
| Gross profit | $13.4 million | $19.8 million | $47.7 million | $54.1 million |
| Gross margin | 47.4% | 48.5% | 46.6% | 48.3% |
| Operating loss | $13.0 million | $3.9 million | $32.7 million | $14.8 million |
| Net loss | $14.3 million | $4.1 million | $36.2 million | $15.3 million |
| Adjusted EBITDA, non-GAAP | $(6.2) million | $2.1 million | $(8.4) million | $0.6 million |
- Revenue mix: Q3 endpoint IC revenue was $21.6 million, down from $26.4 million; systems revenue was $6.6 million, down from $14.4 million. For the first nine months, endpoint IC revenue rose to $73.8 million from $71.9 million, while systems revenue fell to $28.7 million from $40.1 million.
- Cash flow: Operating activities used $13.6 million in the first nine months, versus $0.2 million provided in 2019. Investing activities used $18.0 million and financing activities provided $4.7 million. Cash and cash equivalents declined to $40.1 million from $66.9 million at year-end 2019.
- Liquidity: Cash, cash equivalents and short-term investments totaled $105.1 million; working capital was $144.6 million. Management expected available cash and investments to cover anticipated needs for at least 12 months.
- Debt: The company had $86.25 million principal amount of 2.00% convertible senior notes due 2026, with a $53.6 million balance-sheet carrying value after unamortized discount and issuance costs. Nine-month interest expense was $4.0 million, including substantial noncash discount amortization.
- Other balance-sheet items: Inventory was $38.0 million, up from $34.2 million at year-end. Stockholders’ equity was $109.4 million, down from $125.2 million.
Material changes versus comparable periods
- Q3 revenue fell $12.6 million year over year, with declines in both endpoint IC and systems sales. Management attributed lower endpoint IC volumes primarily to pandemic-related weakness in global retail apparel and lower systems revenue to a prior large gateway deployment moving into its operational phase, plus delayed deployments.
- For the first nine months, revenue declined $9.5 million: endpoint IC growth was more than offset by lower systems revenue. Gross margin fell 1.7 percentage points, mainly because of higher inventory excess and obsolescence charges and product mix.
- Operating expenses increased $2.7 million in Q3 and $11.5 million year to date. Year-to-date general and administrative expense included $5.4 million for the company’s share of a securities-litigation settlement; research and development and stock-based compensation also increased.
- Nine-month inventory excess and obsolescence charges reduced gross margin by 3.2 percentage points, compared with 1.4 points in the prior-year period. The filing identifies a $2.7 million charge in Q1 for older EU-market products affected by weaker demand and a spectrum-band expansion.
Outlook, commentary and risks
- No specific revenue or earnings guidance is provided. Management said the duration and financial magnitude of COVID-19 effects were not reasonably estimable. It expected pandemic effects to continue weighing on results, cash flows and financial position, while demand direction and scale beyond 2020 remained uncertain.
- COVID-19 reduced endpoint IC demand, delayed systems deployments and the M700 product ramp, and disrupted supplier operations and shipping. Suppliers were mostly back to at least 90% of pre-pandemic capacity by June 2020; the company said it believed inventory was sufficient for Q4 endpoint IC demand but gave no assurance on continued supply or timely fulfillment.
- Impinj continued investing in research and development and described the M700 endpoint IC as in production by the end of Q2, but reported a slower-than-expected demand ramp. Management expected R&D spending to increase in absolute dollars, subject to pandemic-related adjustments.
- Key business risks include uncertain adoption of RAIN RFID, dependence on retail and a limited number of channel partners, project-driven variability in systems revenue, price erosion, inventory forecasting, supplier concentration and competition. The company also cited pandemic-related operational, demand and cybersecurity risks.
- Litigation: Impinj agreed to a $20.0 million settlement of federal and New York securities class actions; insurers were to contribute $14.6 million and Impinj paid $5.4 million. The settlement had preliminary court approval, with final approval hearing scheduled for November 19, 2020. A separate derivative-action settlement involving governance changes and up to $0.9 million in counsel fees remained subject to court approval. Patent litigation between Impinj and NXP remained unresolved.
- Commitments: The company disclosed $8.3 million of non-cancelable inventory purchase commitments. Total contractual obligations were $128.6 million, including convertible-note payments and lease commitments net of sublease income.
- Management concluded disclosure controls were effective at a reasonable-assurance level as of September 30, 2020, with no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Whether retail and other end-market demand recovered, and whether the M700 ramp and delayed systems deployments progressed as expected.
- Subsequent gross margins, inventory levels and obsolescence charges, including channel inventory and supplier capacity conditions.
- Operating cash burn and liquidity relative to the company’s stated 12-month funding expectation.
- Final approval and completion of the securities and derivative settlements, and developments in the NXP patent cases.
- Convertible-note terms, potential dilution or cash settlement exposure, and future interest expense from debt-discount amortization.